Understanding Early-life Influenza Antibody Repertoire Imprinting Through Infection or Vaccination
了解生命早期流感抗体库通过感染或疫苗印记
基本信息
- 批准号:10215742
- 负责人:
- 金额:$ 27.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAntibodiesAntibody RepertoireAntibody ResponseAntigensChildDevelopmentEffectivenessExposure toHumanImmune responseImmune systemImmunityInfectionInfluenzaInfluenza vaccinationInstitutesLifeNatureTimeVaccinationVaccinesearly childhoodimprintimprovedinfluenza virus vaccineinfluenzavirusresponsevaccination strategy
项目摘要
Influenza is a persisting global threat, and the most pressing unmet need is to improve vaccination
strategies to be more effective, with this fundamentally hinging on a better understanding of vaccinemediated
immunity in humans. Due to the ubiquitous nature of influenza, people are exposed to influenza
virus at an early age, resulting in the early development of antibody responses to the first encountered
influenza strains. From this initial exposure to influenza via infection or vaccination, the initial influenza
antibody repertoire is established, and it is constantly reshaped during one’s lifetime. Recent studies have
suggested that this initial antibody repertoire generated from the first exposure is ‘imprinted’ in the immune
system and exerts a major influence on the nature of the antibody response elicited upon subsequent
challenges. Such imprinting sets the immune system on a path that bias immune responses to subsequent
exposures to influenza, and there is an increasing understanding that early childhood imprinting might be
the reason for the limited effectiveness of the annual flu vaccination. This study aims to characterize the
immune response to influenza in young children and its effect on subsequent responses to influenza
vaccination. The hypothesis is that that the first exposure through infection results in stronger imprinting of
initial influenza antibody repertoire than the first exposure through vaccination. In Aim 1, the immune
response to influenza vaccine in children who had documented prior natural infection or documented prior
vaccination will be compared, focusing on the persistence of the antibodies from the first time point over 2
years of subsequent vaccinations. In Aim 2, the antibodies comprising the imprinted antibody repertoire will
be functionally characterized to better understand the features of the imprinted antibodies. Collectively, this
study will potentially elucidate the rules and mechanisms governing imprinting, which can be leveraged into
the development of better vaccine immunogens as well as vaccination strategies.
流感是一个持续存在的全球威胁,最紧迫的未满足需求是改善疫苗接种
更有效的策略,基本呈现对疫苗的更好理解
人类的免疫力。
病毒在很小的时候,抗体对第一个遇到的抗体反应的早期发育
流感菌株从初始接触流感,最初的流感
建立了抗体曲目,并且在最近的研究中包含了抗体
建议通过第一次曝光产生的植物抗体是“印象”的免疫
系统并对随后引起的抗体反应的性质产生重大影响
挑战。
对流感的曝光,这是一首越来越多的歌曲,幼儿印迹可能是
年度流感疫苗接种有限有效的原因。
幼儿对流感的免疫反应ATS ETS ETS ETS ETS ETS ETS ETS ETS对随后对流感的反应
疫苗接种。
初始流感抗体比第一次暴露在AIM 1中。
对先前自然感染或事先记录的儿童中流感疫苗的反应
将比较疫苗接种,重点是抗体的持久性,从第一个时间点以上的第一个时间点开始
随后的疫苗接种。
在功能上表征以更好地了解印迹抗体的特征。
研究可能会阐明有关印记的规定和机制,可以将其利用到
开发更好的疫苗免疫原和疫苗接种策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiwon Lee其他文献
Jiwon Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiwon Lee', 18)}}的其他基金
Understanding the impact of imprinted serum antibody repertoire on subsequent vaccine responses
了解印迹血清抗体库对后续疫苗反应的影响
- 批准号:
10271749 - 财政年份:2016
- 资助金额:
$ 27.42万 - 项目类别:
Understanding the impact of imprinted serum antibody repertoire on subsequent vaccine responses
了解印迹血清抗体库对后续疫苗反应的影响
- 批准号:
10460275 - 财政年份:2016
- 资助金额:
$ 27.42万 - 项目类别:
Understanding the impact of imprinted serum antibody repertoire on subsequent vaccine responses
了解印迹血清抗体库对后续疫苗反应的影响
- 批准号:
10647708 - 财政年份:2016
- 资助金额:
$ 27.42万 - 项目类别:
相似国自然基金
条纹斑竹鲨抗体库低丰度功能性纳米抗体的挖掘与筛选研究
- 批准号:42306144
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗MDA5抗体阳性皮肌炎B细胞免疫组库特征分析及抗体功能和致病机制研究
- 批准号:82201979
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SARS-CoV康复者接种新型冠状病毒疫苗后抗体组库分析及抗体应答机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
中东呼吸综合征冠状病毒人源单克隆中和抗体库筛选及协同效应机制研究
- 批准号:32000658
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
抗新型冠状病毒抗体组库分析及其抗病毒机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Mucosal immunity to sapovirus in early childhood
幼儿期对沙波病毒的粘膜免疫
- 批准号:
10677051 - 财政年份:2023
- 资助金额:
$ 27.42万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 27.42万 - 项目类别:
Determinants of HIV broadly-neutralizing antibody precursor induction in infants
婴儿中 HIV 广泛中和抗体前体诱导的决定因素
- 批准号:
10731276 - 财政年份:2023
- 资助金额:
$ 27.42万 - 项目类别:
Determinants of Early Childhood Immune Responses to SARS-CoV-2 Vaccination
幼儿期 SARS-CoV-2 疫苗免疫反应的决定因素
- 批准号:
10715485 - 财政年份:2023
- 资助金额:
$ 27.42万 - 项目类别:
Immune Development Across the Life Course: Integrating Exposures and Multi-Omics in the Boston Birth Cohort
整个生命过程中的免疫发展:在波士顿出生队列中整合暴露和多组学
- 批准号:
10418079 - 财政年份:2022
- 资助金额:
$ 27.42万 - 项目类别: